Pharmaceutical group ยท France
Pierre Fabre
A group of 35 companies with 109 medicines in 8 countries.
Group structure
35 companies in 10 countries
Loadingโฆ
Pharmaceutical group ยท France
A group of 35 companies with 109 medicines in 8 countries.
35 companies in 10 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 109
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Alizem 10 mg zachte capsulesCapsule, zacht | Alitretinoin | Netherlands | Authorised | 2019 |
| Alizem 30 mg zachte capsulesCapsule, zacht | Alitretinoin | Netherlands | Authorised | 2019 |
| Braftovi | Encorafenib | EU (EMA) | Authorised | 2018 |
| BRAFTOVI 50 MG CAPSULAS DURAS50 mg ยท Cรกpsula dura | Encorafenib | Spain | Marketed | 2018 |
| Braftovi 50 mg capsule, hardCapsule, hard | Encorafenib | Netherlands | Authorised | 2018 |
| BRAFTOVI 75 MG CAPSULAS DURASIgual a 75 mg mg ยท Cรกpsula dura | Encorafenib | Spain | Marketed | 2018 |
| Braftovi 75 mg capsule, hardCapsule, hard | Encorafenib | Netherlands | Authorised | 2018 |
| BRAFTOVI HARD CAPSULE 50MG50mg ยท Capsule | Encorafenib | Singapore | Authorised | 2023 |
| BRAFTOVI HARD CAPSULE 75MG75mg ยท Capsule | Encorafenib | Singapore | Authorised | 2023 |
| Clarelux 500 microgram/g schuim voor cutaan gebruik in spuitbusSchuim voor cutaan gebruik | Clobetasol | Netherlands | Authorised | 2004 |
| CLARELUX 500 microgramos/g ESPUMA CUTANEA EN ENVASE A PRESION.0,05 Porcentaje peso/peso ยท Espuma cutรกnea | Clobetasol | Spain | Marketed | 2004 |
| DOXICLAT 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg ยท Comprimido recubierto | Doxycycline | Spain | Marketed | 1972 |
| Ebvallo | Tabelecleucel | EU (EMA) | Authorised | 2022 |
| EBVALLO 2,8 ร 10E7 - 7,3 ร 10E7 CรLULAS /ML DISPERSION INYECTABLE5 x 10E7 cรฉlulas/ml ยท Dispersiรณn inyectable | Tabelecleucel | Spain | Authorised | 2023 |
| Ebvallo 5ร10E7 cellen/ml, dispersie voor injectieDispersie voor injectie | Tabelecleucel | Netherlands | Authorised | 2022 |
| FABROVEN 150 mg/150 mg/100 mg CAPSULAS DURAS150 mg + 150 mg + 100 mg ยท Cรกpsula dura | Hesperidina metilchalcona, Ruscus aculeatus exto, Ascorbic acid | Spain | Marketed | 1994 |
| Hemangiol | Propranolol | EU (EMA) | Authorised | 2014 |
| HEMANGIOL3.75 mg / ml ยท Solution | Propranolol | Canada | Marketed | 2017 |
| HEMANGIOL 3,75 mg/ml, drankDrank | Propranolol | Netherlands | Authorised | 2014 |
| HEMANGIOL 3,75 MG/ML SOLUCION ORAL3,75 mg ยท Soluciรณn oral | Propranolol | Spain | Marketed | 2014 |
| ISOACNE 10 mg CAPSULAS BLANDAS10,000 mg ยท Cรกpsula blanda | Isotretinoin | Spain | Marketed | 2006 |
| ISOACNE 20 mg CAPSULAS BLANDAS20,000 mg ยท Cรกpsula blanda | Isotretinoin | Spain | Marketed | 2006 |
| ISOACNE 40 mg CAPSULAS BLANDAS40,00 mg ยท Cรกpsula blanda | Isotretinoin | Spain | Marketed | 2008 |
| ISOACNE 5 mg CAPSULAS BLANDAS5,00 mg ยท Cรกpsula blanda | Isotretinoin | Spain | Marketed | 2006 |
| Javlor | Vinflunine | EU (EMA) | Authorised | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 38 | 29 | 9 | CompaniesAll medicines |
| Canada | 24 | 7 | 17 | CompaniesAll medicines |
| Netherlands | 19 | 19 | 0 | CompaniesAll medicines |
| European Union (EMA) | 11 | 7 | 4 | CompaniesAll medicines |
| Romania | 9 | 0 | 9 | CompaniesAll medicines |
| Singapore | 5 | 5 | 0 | CompaniesAll medicines |
| Croatia | 2 | 2 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Brazil, Colombia, France, Germany, Italy, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Federal Commercial Registry Office;exact dataset/law title,source URI/link and retrieval date;Prognia separately labelled normalization;no endorsement.
Licence: opendata.swiss terms_by
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Bundesinstitut fรผr Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licence: commercial redistribution permission not established
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche dโentreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerstwo Sprawiedliwoลci / Krajowy Rejestr Sฤ dowy; original source URL, literal IDs and source locators, original creation/snapshot dates where present and acquisition time; selected fields normalized by Prognia; original statutory/MOJ reuse conditions
Licence: Statutory public-register API reuse with attribution conditions
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Pierre Fabreโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.